GGrantIndex
← Leaderboards

John P Konhilas

University Of Colorado At Boulder

$6,314,823
Attributed
$8,104,007
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $697K · FY200625
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,104,007 · 5

By mechanism

T32$4,937,517 · 1
R01$1,916,777 · 1
K01$600,480 · 1
K02$515,565 · 1
F32$133,668 · 1

Top collaborators

Most similar at University Of Colorado At Boulder

Same institution · by research overlap

Others in their field

Top investigators on “Mediator Of Activation Protein

Research focus

Mediator Of Activation ProteinHeart DiseasesMyocardial InfarctionLinkClinically SignificantDisease ProgressionHypertrophic CardiomyopathyMetabolicPathway InteractionsCardiacSiteMyosin Heavy ChainsTrainingProtein IsoformsAwardAdenosine MonophosphateFunctional DisorderFemaleEtiologyFoundationsFundingBiometryCardiovascular Diseases-Amp-Activated Protein Kinase

Grant awards (28)

Interdisciplinary Training in Cardiovascular Research$696,357
T32 · FY2025 · HL · contact PI
Interdisciplinary Training in Cardiovascular Research$662,163
T32 · FY2024 · HL · contact PI
Interdisciplinary Training in Cardiovascular Research$696,986
T32 · FY2023 · HL · contact PI
Interdisciplinary Training in Cardiovascular Research$394,737
T32 · FY2021 · HL
Interdisciplinary Training in Cardiovascular Research$647,175
T32 · FY2020 · HL
Interdisciplinary Training in Cardiovascular Research$627,380
T32 · FY2019 · HL
Interdisciplinary Training in Cardiovascular Research$612,550
T32 · FY2018 · HL
Interdisciplinary Training in Cardiovascular Research$600,169
T32 · FY2017 · HL
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$103,113
K02 · FY2015 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$420,622
R01 · FY2014 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$103,113
K02 · FY2014 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$354,033
R01 · FY2013 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$103,113
K02 · FY2013 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$19,138
R01 · FY2013 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$371,974
R01 · FY2012 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$103,113
K02 · FY2012 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$375,819
R01 · FY2011 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$103,113
K02 · FY2011 · HL · contact PI
Impact of AMP-activated kinase on sex differences in hypertrophic cardiomyopathy$375,191
R01 · FY2010 · HL · contact PI
Metabolism, Skeletal Muscle, Cardiac Disease, Exercise$120,096
K01 · FY2010 · AR · contact PI
Metabolism, Skeletal Muscle, Cardiac Disease, Exercise$120,096
K01 · FY2009 · AR · contact PI
Metabolism, Skeletal Muscle, Cardiac Disease, Exercise$91,707
K01 · FY2008 · AR · contact PI
Metabolism, Skeletal Muscle, Cardiac Disease, Exercise$28,389
K01 · FY2008 · AR · contact PI
Metabolism, Skeletal Muscle, Cardiac Disease, Exercise$120,096
K01 · FY2007 · AR · contact PI
Metabolism, Skeletal Muscle, Cardiac Disease, Exercise$120,096
K01 · FY2006 · AR · contact PI
Signaling in pathological &physiological hypertrophy$48,928
F32 · FY2004 · HL
Signaling in pathological &physiological hypertrophy$46,420
F32 · FY2003 · HL
Signaling in pathological &physiological hypertrophy$38,320
F32 · FY2002 · HL